G

Glaukos Corp

GKOS

117.910
USD
0.74
(0.63%)
Market Closed
Volume
11,530
EPS
0
Div Yield
0
P/E
-41
Market Cap
7,232,579,414
Related Instruments
AAPL
-3.610
(-1.63%)
218.370 USD
ABT
4.220
(3.98%)
110.150 USD
A
ALGN
-3.810
(-1.64%)
228.270 USD
AMZN
-3.000
(-1.60%)
183.990 USD
EW
-1.220
(-1.94%)
61.830 USD
GOOGL
-0.710
(-0.41%)
170.760 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
SYK
5.59
(1.71%)
332.94 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: Glaukos Corp

Sector: Healthcare
Industry: Medical Devices
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.